Clinical Study Validates BabyOrgano's Baalprashan as India's First Clinically Tested Baalprashan Swarnaprashan Drops for Children

VMPL
Ahmedabad (Gujarat) [India], April 6: BabyOrgano's Baalprashan Swarnaprashan Drops have shown promising outcomes in supporting the overall growth and immunity of children. This has been highlighted by findings from a recent clinical evaluation. The study offers validation to an age-old Ayurvedic practice, showing the role of traditional formulations in nurturing children during their crucial growing years.

The clinical study assessed the safety and efficacy of BabyOrgano Baalprashan Drops administered consistently over a defined period. Children across different age groups participated in the evaluation, with age-appropriate dosages provided daily. The outcomes were measured across multiple parameters including immunity, physical growth, recovery rate, and overall wellbeing.
According to the findings, the formulation demonstrated a significant improvement in key immunity markers, with Immunoglobulin A (IgA) and Immunoglobulin G (IgG) levels increasing by approximately 25%. These markers play a vital role in strengthening the body's defense system, indicating enhanced immune response among children consuming the drops.
One of the most notable observations from the study was the reduction in recovery time. Children who previously took around six days to recover from common illnesses showed a faster recovery period of nearly two days during the course of the study. Additionally, the number of sick days reduced considerably from an average of 3.5 days to 1.3 days, suggesting improved resilience against recurring infections.
The study also highlighted a 44% improvement in overall wellbeing, as reported through structured assessments and parental feedback. Parents observed positive changes in their children's daily energy levels, activity, and general health.
In terms of physical development, the formulation showed encouraging results. Participants noticed improvements in growth parameters, including a 31.2% increase in weight and a 22.5% improvement in height over the study period. These findings suggest that Baalprashan Drops may support not just immunity but also healthy physical development in growing children.
The formulation showed no adverse effects reported during the study. Compliance levels remained high, indicating ease of administration and acceptance among children.
Speaking about the vision behind the brand, founders Ridhhi Sharma and Ripul Sharma shared, "Our goal has always been to bring Ayurveda for today's parents in a way that is both effective and trustworthy. We believe that ancient knowledge, when backed by research and innovation, can play a powerful role in supporting children's health. In simple terms, we want to bring Dadi-Nani Ke Nushke to today's children in a convenient way."
BabyOrgano stands out for its strong focus on research and development, with an in-house R&D laboratory dedicated to creating safe, effective, and child-friendly Ayurvedic formulations. Each product is carefully developed using high-quality ingredients and follows strict quality standards to ensure consistency and efficacy.
Baalprashan, inspired by the traditional Ayurvedic practice of Swarnaprashan, is known for its role in supporting immunity, cognitive development, and overall growth in children. BabyOrgano's formulation is designed to deliver these benefits in a convenient and modern format, making it easier for parents to add to their child's daily routine.
With increasing awareness among parents about natural and preventive healthcare, such clinically supported Ayurvedic solutions are gaining wider acceptance. The findings from this study further strengthen the position of Baalprashan Drops as a reliable supplement for supporting children's health holistically.
As BabyOrgano continues to work in research and innovate, the brand aims to bridge the gap between traditional Ayurvedic wisdom and modern parenting needs, ensuring that children grow healthier, stronger, and more resilient.
(ADVERTORIAL DISCLAIMER: The above press release has been provided by VMPL. ANI will not be responsible in any way for the content of the same.)